Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,371,600 papers from all fields of science
Search
Sign In
Create Free Account
azilsartan
Known as:
2-ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-biphenyl-4-yl)methyl)-1H-benzimidazole-7-carboxylic acid
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
Angiotensin 2 Type 1 Receptor Antagonists [MoA]
Decreased Blood Pressure [PE]
azilsartan / Chlorthalidone
azilsartan medoxomil 40 MG Oral Tablet [Edarbi]
Narrower (4)
Azilsartan kamedoxomil
Edarbi
TAK-536
azilsartan medoxomil
Broader (2)
Benzimidazoles
Oxadiazoles
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Effects of azilsartan compared with telmisartan on insulin resistance in patients with essential hypertension and type 2 diabetes mellitus: An open-label, randomized clinical trial
M. Naruse
,
Yasuhiro Koike
,
Nozomu Kamei
,
R. Sakamoto
,
Y. Yambe
,
Michinori Arimitsu
PLoS ONE
2019
Corpus ID: 92998463
Background Based on non-clinical data, it is expected that azilsartan, an angiotensin II receptor blocker, will help improve…
Expand
2018
2018
Effects of Olmesartan and Azilsartan on Albuminuria and the Intrarenal Renin-Angiotensin System.
T. Takami
,
Sadanori Okada
,
Yoshihiko Saito
,
Y. Nishijima
,
H. Kobori
,
A. Nishiyama
World Journal of Research and Review
2018
Corpus ID: 5054754
Purpose Olmesartan and azilsartan decrease blood pressure more effectively than other angiotensin receptor blockers (ARBs). ARBs…
Expand
2016
2016
Changeover Trial of Azilsartan and Olmesartan Comparing Effects on the Renin-Angiotensin-Aldosterone System in Patients with Essential Hypertension after Cardiac Surgery (CHAOS Study).
A. Sezai
,
S. Osaka
,
+4 authors
Hisakuni Sakino
Annals of Thoracic and Cardiovascular Surgery
2016
Corpus ID: 24224313
BACKGROUND Angiotensin II receptor blockers (ARBs) have been widely used to treat hypertension and large-scale clinical studies…
Expand
2016
2016
Azilsartan Improves Salt Sensitivity by Modulating the Proximal Tubular Na+-H+ Exchanger-3 in Mice
M. Hatanaka
,
J. Kaimori
,
+7 authors
H. Rakugi
PLoS ONE
2016
Corpus ID: 15134183
A potent angiotensin II type-1 receptor blocker, azilsartan, has been reported to reduce blood pressure more effectively than…
Expand
2016
2016
Will Azilsartan - An Eight ARB Bring Paradigm Shift in HypertensionManagement Practices in India?
Abhijit Trailokya
2016
Corpus ID: 79048932
Hypertension, a common cardiovascular disease, should take the most accountability for the morbidity and mortality caused by…
Expand
2014
2014
Method Development and Validation for the Simultaneous Estimation of Azilsartan and Chlorthalidone by RP-HPLC in Pharmaceutical Dosage Form
P. Sravani
,
S. R. Kumar
,
N. Devanna
2014
Corpus ID: 101396961
A simple, precise, accurate method was developed for the simultaneous estimation of azilsartan and chlorthalidone in…
Expand
2014
2014
Effect of azilsartan versus candesartan on morning blood pressure surges in Japanese patients with essential hypertension
H. Rakugi
,
K. Kario
,
K. Enya
,
Kenkichi Sugiura
,
Yoshinori Ikeda
Blood Pressure Monitoring
2014
Corpus ID: 6999652
Morning blood pressure (BP) surge is reported as a risk factor for cardiovascular events and end-organ damage independent of the…
Expand
2014
2014
Azilsartan is More Effective as Compared to Olmesartan in Hemodialysis Patients with Uncontrolled Hypertension
A. Ukimura
,
H. Matsuda
,
+5 authors
S. Ono
2014
Corpus ID: 55811370
Background: Azilsartan is a new angiotensin receptor blocker with more continuous antihypertensive effects. The objective of this…
Expand
2013
2013
New angiotensin II type 1 receptor blocker, azilsartan, attenuates cardiac remodeling after myocardial infarction.
Yuichi Nakamura
,
Satoshi Suzuki
,
Shu-ichi Saitoh
,
Y. Takeishi
Biological and Pharmaceutical Bulletin
2013
Corpus ID: 40792525
After an acute myocardial infarction (MI), neurohumoral systems including renin-angiotensin-aldosterone system (RAAS) are…
Expand
Review
2012
Review
2012
Telmisartan improves insulin sensitivity: a meta-analysis of randomized head-to-head trials.
H. Takagi
,
T. Umemoto
International Journal of Cardiology
2012
Corpus ID: 10940477
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE